Differences between revisions 48 and 49
Revision 48 as of 2005-12-05 19:35:43
Size: 1329
Editor: mskresolve-b
Comment:
Revision 49 as of 2005-12-05 19:36:46
Size: 1392
Editor: mskresolve-b
Comment:
Deletions are marked like this. Additions are marked like this.
Line 39: Line 39:
Once posted to the wiki, the RFC owner should announce it via the cytostaff emailing list, and provide a specific deadline for public discussion. Once posted to the wiki, the RFC owner should announce it via the cytostaff emailing list, and provide a specific deadline for public discussion.  RFCs should be open for public comment for at least one week.

TableOfContents([2])

About this Document

This is an official Request for Comment (RFC) for "improving the quality of the Cytoscape 2.3 release."

RFC 2 is divided in three parts:

  • Part I consists of Ethan's interviews with six Cytoscapers (Trey, Gary, Ben, Allan, Aditya, and Rowan).
  • Part II consists of ideas generated at the 2005 Cytoscape retreat.
  • Part III consists of final, concreate ideas, which are being proposed to the Cytoscape group.

Status

This document is under construction.

Part I: The Interviews

["/Part 1"]

Part II: Results from 2005 Cytoscape Retreat

["/Part 2"]

Part III: Final Proposals

1. Adopt a Formal RFC Process for Each New Feature / Refactoring in Cytoscape 2.3

Each new feature / refactoring slated for Cytoscape 2.3 will go through a public review process via an RFC posted to the Cytoscape Wiki.

["RFC_1"] will serve as a starting template for all RFCs.

Depending on the feature, the RFC should include the following:

  • Use case addressed.
  • Proposed user interface.
  • Proposed API.

Once posted to the wiki, the RFC owner should announce it via the cytostaff emailing list, and provide a specific deadline for public discussion. RFCs should be open for public comment for at least one week.

Add a comment about this idea: ["/RFC_Comment"]


RFC_2 (last edited 2009-02-12 01:04:11 by localhost)

Funding for Cytoscape is provided by a federal grant from the U.S. National Institute of General Medical Sciences (NIGMS) of the Na tional Institutes of Health (NIH) under award number GM070743-01. Corporate funding is provided through a contract from Unilever PLC.

MoinMoin Appliance - Powered by TurnKey Linux